
The PARITY Trial

The PARITY Trial
A Trial Comparing Prophylactic Intravenous Antibiotic Regimens Following Endoprosthetic Reconstruction for Lower Extremity Bone Tumors
JAMA Oncol . 2022 Jan 6;e216628.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Six hundred and eleven patients undergoing surgical resection and endoprosthetic reconstruction for lower extremity bone tumors were randomized to receive a one-day regimen (n=312) or five-day regimen (n=299) of post-operative prophylactic intravenous antibiotics. The primary outcome was surgical site infection as classified according to the criteria established by the Centers for Disease Control ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.